about vx-880 - SERP Analysis

https://www.breakthrought1d.org/news-and-updates/vertex-launches-pivotal-trial-for-stem-cell-derived-islet-therapy/

https://investors.vrtx.com/news-releases/news-release-details/vertex-presents-positive-vx-880-results-ongoing-phase-12-study

https://www.cgtlive.com/view/vertex-islet-cell-therapy-vx-880-restores-endogenous-insulin-secretion-type-1-diabetes

https://news.vrtx.com/news-releases/news-release-details/vertex-announces-positive-results-ongoing-phase-12-study-vx-880

https://www.hsci.harvard.edu/news/new-therapy-treating-type-1-diabetes

https://clinicaltrials.gov/study/NCT04786262

https://diabetes.org/newsroom/press-releases/expanded-forward-trial-demonstrates-continued-potential-stem-cell-derived

https://breakthrought1d.org.uk/about-breakthrough-t1d-uk-and-our-impact/our-research/cure-research/vertexs-clinical-trials-of-lab-grown-insulin-making-cells/vx-880-clinical-trial/

https://www.clinicaltrialsarena.com/news/vertex-type-1-diabetes-trial/

https://www.thejdca.org/publications/report-library/archived-reports/2024-reports/vertex-t1d-trial-moves-into-phase-iii.html

https://www.fiercebiotech.com/biotech/vertex-pauses-diabetes-cell-therapy-trial-after-2-unrelated-patient-deaths

https://diabetesjournals.org/diabetes/article/72/Supplement_1/836-P/149653/836-P-Glucose-Dependent-Insulin-Production-and

https://beyondtype1.org/vertex-clinical-trial-study-easd/

https://www.thejdca.org/publications/report-library/archived-reports/2024-reports/vx-880-update-3-insulin-independent-with-7-expected-to-follow.html

https://www.biospace.com/vertex-presents-positive-updated-vx-880-results-from-ongoing-phase-1-2-study-in-type-1-diabetes-at-the-european-association-for-the-study-of-diabetes-59th-annual-meeting

https://www.cgtlive.com/view/vertex-diabetes-cell-therapy-vx-880-eliminating-severe-hypoglycemic-events

https://type1better.com/en/vx-880-a-new-stem-cell-derived-experimental-therapy-for-people-with-type-1-diabetes/

https://www.hcplive.com/view/forward-vx-880-could-eliminate-need-for-insulin-in-patients-with-type-1-diabetes

https://www.businesswire.com/news/home/20250328622122/en/Vertex-Announces-Program-Updates-for-Type-1-Diabetes-Portfolio

https://breakthrought1d.ca/important-update-on-vertex-trials/

https://www.insideprecisionmedicine.com/topics/precision-medicine/islet-cell-therapy-breaks-through-three-patients-become-insulin-independent-in-vertex-type-1-diabetes-trial/

https://www.biospace.com/drug-development/vertex-cuts-diabetes-asset-but-analysts-keen-on-phase-iii-option

https://www.type1strong.org/blog-post/vertex-t1d-trial-vx-880-moves-into-phase-iii

https://www.reddit.com/r/diabetes_t1/comments/1dlvk6j/vertex_announces_promising_results_from_vx880/

https://beyondtype1.org/diabetes-stem-cell-trial-vertex-270/

https://www.breakthrought1d.org/news-and-updates/vertex/

https://diatribe.org/diabetes-medications/vertex-releases-new-data-potential-cure-type-1-diabetes

https://www.hra.nhs.uk/planning-and-improving-research/application-summaries/research-summaries/phase-12-study-to-evaluate-the-safety-tolerability-and-efficacy-of-vx-880-in-t1d-subjects/

https://www.managedhealthcareexecutive.com/view/phase-3-trial-of-vertex-s-islet-cell-therapy-for-type-1-diabetes-in-under-way

https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-human-stem-cell-derived-pancreatic-islet-cells-vx-880

https://www.reddit.com/r/diabetes_t1/comments/14k79p3/my_summary_of_vertexs_vx880_study_very_exciting/

https://www.businesswire.com/news/home/20220502005336/en/Vertex-Provides-Updates-on-Phase-12-Clinical-Trial-of-VX-880-for-the-Treatment-of-Type-1-Diabetes

https://www.neuro-central.com/vertex-presents-new-data-from-vx-880-phase-1-2-clinical-trial-at-the-american-diabetes-association-82nd-scientific-sessions/

https://platform.mytomorrows.com/trial-details/NCT04786262

https://t1dexchange.org/vertex-islet-cell-therapy-type-1-diabetes/

https://www.drwf.org.uk/news-and-events/news/recent-studies-show-promise-in-islet-cell-therapy-for-type-1-diabetes/

https://ctv.veeva.com/study/an-efficacy-safety-and-tolerability-study-of-vx-880-in-participants-with-type-1-diabetes-with-a-ki

https://www.healio.com/news/endocrinology/20250328/novel-islet-cell-therapy-eliminates-severe-hypoglycemia-cuts-hba1c-in-type-1-diabetes

https://diabetesed.net/new-treatment-for-type-1-diabetes-vx-880/

https://synapse.patsnap.com/article/new-data-strengthens-vertex-cell-therapys-type-1-diabetes-potential

https://asgct.careboxhealth.com/en-US/trial/listing/295159

https://firstwordpharma.com/story/5607943

https://www.ajmc.com/view/vx-880-shows-promise-for-insulin-glucose-management-in-t1d-in-new-data

https://www.connectedinmotion.ca/blog/vx-880-islet-cell-therapy-a-new-frontier-in-t1d-treatment/

https://globalgenes.org/raredaily/fda-lifts-clinical-hold-on-vertexs-experimental-cell-therapy-for-type-1-diabetes/

https://www.youtube.com/watch?v=xL7mdlFCoE8

https://www.hcplive.com/view/data-potential-vx-880-insulin-independence-t1d

https://www.pharmabiz.com/NewsDetails.aspx?aid=169911&sid=2

https://www.uchicagomedicine.org/find-a-clinical-trial/clinical-trial/irb201617

https://www.diabetesincontrol.com/stem-cell-transplant-in-type-1-diabetes/

https://diabetes.org/sites/default/files/2024-06/ADA_Vertex_PressRelease_FINAL.pdf

https://clinicaltrials.eu/trial/study-on-the-safety-and-effectiveness-of-vx-880-for-patients-with-type-1-diabetes-and-severe-low-blood-sugar-awareness/

https://firstwordpharma.com/story/5583881

https://www.bdsn.de/vertex-releases-new-data-on-its-potential-type-1-diabetes-cure/

https://www.linkedin.com/posts/tao-cong_allogeneic-celltherapy-insulin-activity-7190515573473058816-_NnC

https://t1dexchange.org/vertex-qa-promising-new-data-future-of-cell-therapies/

https://desang.net/2025/03/vertex-new-data-on-cure-for-t1d/

https://www.researchgate.net/publication/371817288_836-P_Glucose-Dependent_Insulin_Production_and_Insulin-Independence_in_Type_1_Diabetes_from_Stem_Cell-Derived_Fully_Differentiated_Islet_Cells-Updated_Data_from_the_VX-880_Clinical_Trial

https://breakthrought1d.ca/exciting-updates-from-vertex-stem-cell-based-therapy-clinical-trials/

https://www.withpower.com/trial/phase-2-diabetes-mellitus-type-1-2-2021-9345d

https://www.managedhealthcareexecutive.com/view/stem-cell-transplant-shows-potential-in-early-research-for-type-1-diabetes

https://www.drugdiscoverytrends.com/vertex-pharmaceuticals-wins-fda-fast-track-designation-for-its-cell-based-diabetes-treatment/

https://finance.yahoo.com/news/vertex-announces-positive-results-ongoing-194500174.html

https://www.youtube.com/watch?v=P56JMvRlJCI

https://euclinicaltrials.eu/ctis-public/view/2024-513929-23-00

https://www.drugdeliverybusiness.com/fda-vertex-insulin-cell-therapy-diabetes/

https://www.addrm.online/abstract/improvement-in-glycemic-control-and-elimination-of-exogenous-insulin-use-in-patients-with-type-1-diabetes-infused-with-fully-differentiated-islet-cells-vx-880/

https://via.ritzau.dk/pressemeddelelse/13652760/ma-vertex-pharma?publisherId=90456

https://www.instagram.com/reel/DB96M8OMEl6/?hl=en

https://www.linkedin.com/posts/the-diatribe-foundation_type1diabetes-vx880-medicalbreakthrough-activity-7241834102960631809-u7m6

https://diatribe.org/diabetes-research/join-trial-testing-potential-cure-type-1-diabetes

https://breakthrought1d.org.uk/news/promising-stem-cell-therapy-for-type-1-given-green-light-to-progress/

https://www.fiercepharma.com/pharma/vertex-enlists-treefrog-enhance-production-type-1-diabetes-cell-therapy-candidates

https://www.guidelinecentral.com/clinical-trial/?id=NCT04786262

https://x.com/BreakthroughT1D/status/1804271127965110463

https://www.lonza.com/news/2023-06-26-13-30

https://www.fiercebiotech.com/biotech/unwelcome-surprise-vertex-fda-slaps-hold-phase-12-diabetes-cell-therapy-study

https://synapse.patsnap.com/blog/vertex-shares-results-of-phase-12-trial-of-vx-880-for-type-1-diabetes

https://oilnow.gy/business-wire/vertex-presents-positive-vx-880-results-from-ongoing-phase-1-2-study-in-type-1-diabetes-at-the-american-diabetes-association-83rd-scientific-sessions/

https://diabetesresearch.org/diabetes-research-institute-contributes-to-promising-results-in-vertex-phase-1-2-clinical-trial-for-type-1-diabetes-treatment/

https://www.medscape.com/viewarticle/vertex-pauses-islet-cell-study-after-patient-deaths-2024a10000oe

https://hscrb.harvard.edu/news/a-new-therapy-for-treating-type-1-diabetes/

https://dcodeddiabetes.com/vertex_trials/

https://www.facebook.com/BreakthroughT1DEasternIowa/posts/%EF%B8%8F-exciting-updates-from-the-vertex-pharmaceuticals-clinical-trial-of-vx-880-a-gr/491489256882026/

https://www.clinicaltrialsarena.com/features/vertex-stem-cell-therapy-diabetes-cure/

https://www.samedanltd.com/press-releases/vertex-presents-positive-updated-vx-880-results-from-ongoing-phase-1-2-study-in-type-1-diabetes-at-the-european-association-for-the-study-of-diabetes-59th-annual-meeting/

https://diabetesjournals.org/diabetes/article/71/Supplement_1/259-OR/145478/259-OR-Stem-Cell-Derived-Fully-Differentiated

https://www.sec.gov/Archives/edgar/data/875320/000087532022000022/ex991_pressreleasejuly1120.htm

https://www.nature.com/articles/s41587-022-01443-7

https://www.adventhealth.com/foundation/adventhealth-foundation-central-florida/blog/t1d-research-watch-2022

https://pittplusme.org/study/2325

https://www.advisory.com/daily-briefing/2021/11/30/t1d-treatment

https://clinicaltrials.ucsf.edu/trial/NCT04786262

https://www.pharmabiz.com/PrintArticle.aspx?aid=169911&sid=2

https://onlinelibrary.wiley.com/doi/10.1111/jdi.13884

https://www.regmednet.com/potential-cell-therapy-for-type-1-diabetes-novel-data-from-phase-i-ii-clinical-trial/

https://clinicaltrials.eu/inn/stx-02/

https://www.nejm.org/doi/abs/10.1056/NEJMoa2506549

https://www.facebook.com/breakthrought1dhq/videos/vertex-update-110424/567762985906010/